News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
761,756 Results
Type
Article (51919)
Company Profile (308)
Press Release (709518)
Multimedia
Podcasts (104)
Webinars (17)
Section
Business (213160)
Career Advice (2131)
Deals (36720)
Drug Delivery (119)
Drug Development (84155)
Employer Resources (174)
FDA (17261)
Job Trends (15839)
News (361153)
Policy (34949)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2811)
Accelerated approval (33)
Adcomms (29)
Allergies (146)
Alliances (51850)
ALS (175)
Alzheimer's disease (1754)
Antibody-drug conjugate (ADC) (319)
Approvals (17526)
Artificial intelligence (550)
Autoimmune disease (160)
Automation (40)
Bankruptcy (375)
Best Places to Work (12112)
BIOSECURE Act (20)
Biosimilars (191)
Biotechnology (197)
Bladder cancer (159)
Brain cancer (59)
Breast cancer (657)
Cancer (4920)
Cardiovascular disease (419)
Career advice (1807)
Career pathing (39)
CAR-T (288)
CDC (50)
Celiac Disease (2)
Cell therapy (761)
Cervical cancer (38)
Clinical research (71661)
Collaboration (1770)
Company closure (4)
Compensation (1164)
Complete response letters (57)
COVID-19 (2843)
CRISPR (91)
C-suite (880)
Cystic fibrosis (144)
Data (6306)
Decentralized trials (2)
Denatured (37)
Depression (148)
Diabetes (514)
Diagnostics (6912)
Digital health (51)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (257)
Drug pricing (195)
Drug shortages (31)
Duchenne muscular dystrophy (234)
Earnings (92433)
Editorial (63)
Employer branding (21)
Employer resources (153)
Events (122677)
Executive appointments (1002)
FDA (20465)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (24)
Funding (1517)
Gene editing (201)
Generative AI (51)
Gene therapy (611)
GLP-1 (1036)
Government (4955)
Grass and pollen (6)
Guidances (385)
Healthcare (19991)
HIV (60)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (258)
Immuno-oncology (58)
Indications (111)
Infectious disease (3123)
Inflammatory bowel disease (195)
Inflation Reduction Act (14)
Influenza (120)
Intellectual property (251)
Interviews (327)
IPO (17031)
IRA (51)
Job creations (4072)
Job search strategy (1517)
JPM (60)
Kidney cancer (16)
Labor market (85)
Layoffs (569)
Leadership (34)
Legal (8525)
Liver cancer (95)
Longevity (15)
Lung cancer (668)
Lymphoma (379)
Machine learning (43)
Management (59)
Manufacturing (812)
MASH (169)
Medical device (14813)
Medtech (14869)
Mergers & acquisitions (20767)
Metabolic disorders (1325)
Multiple sclerosis (162)
NASH (16)
Neurodegenerative disease (343)
Neuropsychiatric disorders (96)
Neuroscience (3050)
Neurotech (1)
NextGen: Class of 2026 (6939)
Non-profit (4785)
Now hiring (67)
Obesity (628)
Opinion (276)
Ovarian cancer (168)
Pain (206)
Pancreatic cancer (233)
Parkinson's disease (293)
Partnered (34)
Patents (502)
Patient recruitment (502)
Peanut (58)
People (61895)
Pharmaceutical (68)
Pharmacy benefit managers (31)
Phase 1 (22312)
Phase 2 (31461)
Phase 3 (23504)
Pipeline (5342)
Policy (292)
Postmarket research (2744)
Preclinical (9518)
Press Release (67)
Prostate cancer (245)
Psychedelics (50)
Radiopharmaceuticals (289)
Rare diseases (861)
Real estate (6371)
Recruiting (70)
Regulatory (26007)
Reports (52)
Research institute (2561)
Resumes & cover letters (363)
Rett syndrome (27)
RNA editing (17)
RSV (80)
Schizophrenia (157)
Series A (248)
Series B (197)
Service/supplier (12)
Sickle cell disease (99)
Special edition (24)
Spinal muscular atrophy (162)
Sponsored (43)
Startups (3881)
State (2)
Stomach cancer (18)
Supply chain (108)
Tariffs (87)
The Weekly (65)
Vaccines (1057)
Venture capital (92)
Weight loss (418)
Women's health (94)
Worklife (18)
Date
Last 7 days (631)
Last 30 days (2066)
Last 365 days (30530)
2026 (3522)
2025 (30959)
2024 (36165)
2023 (41206)
2022 (52438)
2021 (57163)
2020 (55951)
2019 (48868)
2018 (36995)
2017 (33813)
2016 (33684)
2015 (39728)
2014 (33459)
2013 (28751)
2012 (30987)
2011 (31634)
2010 (29997)
Location
Africa (813)
Alabama (85)
Alaska (7)
Arizona (318)
Arkansas (14)
Asia (42564)
Australia (7018)
California (11415)
Canada (3308)
China (1150)
Colorado (492)
Connecticut (497)
Delaware (343)
Europe (92793)
Florida (1704)
Georgia (367)
Hawaii (3)
Idaho (65)
Illinois (919)
India (66)
Indiana (529)
Iowa (22)
Japan (439)
Kansas (129)
Kentucky (40)
Louisiana (27)
Maine (72)
Maryland (1431)
Massachusetts (8258)
Michigan (335)
Minnesota (653)
Mississippi (6)
Missouri (130)
Montana (32)
Nebraska (28)
Nevada (127)
New Hampshire (84)
New Jersey (3057)
New Mexico (31)
New York (3021)
North Carolina (1537)
North Dakota (8)
Northern California (5563)
Ohio (335)
Oklahoma (21)
Oregon (42)
Pennsylvania (2300)
Puerto Rico (24)
Rhode Island (50)
South America (1198)
South Carolina (68)
South Dakota (1)
Southern California (4444)
Tennessee (178)
Texas (1782)
United States (40859)
Utah (340)
Vermont (1)
Virginia (266)
Washington D.C. (84)
Washington State (955)
West Virginia (4)
Wisconsin (116)
Wyoming (2)
761,756 Results for "neuros medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Podcast
Weight Loss Waves, Pazdur’s Exit and FDA Instability, New Neuro Breakthroughs
Pfizer deals again in obesity space as Wave and Structure drop splashy weight loss results; what CDER Director Richard Pazdur’s sudden retirement means for biopharma; neuro diseases take center stage at CTAD; and more.
December 10, 2025
·
1 min read
·
Heather McKenzie
Press Releases
Rakovina Therapeutics Inc. Announces Presentation of Second Abstract at the 2025 Society for Neuro-Oncology Annual Meeting
November 24, 2025
·
4 min read
Press Releases
ClearPoint Neuro Completes Acquisition of IRRAS
November 21, 2025
·
5 min read
Drug Development
Biopharma Momentum To Propel Rare Disease, Cancer, Neuro Forward in 2026
After years stuck in the “doldrums,” the biopharma sector is in a “very good place” heading into the new year, analysts told
BioSpace
, with both rare and chronic diseases headlining investor and R&D interest as JPM26 kicks off.
January 12, 2026
·
6 min read
·
Heather McKenzie
Press Releases
ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer
September 25, 2025
·
5 min read
Opinion
Patient-Centered Paradigms Can Boost Neuro Candidate Success Rates
Innovative outcome measures coupled with a focus on patient-centered clinical differentiation can help the biopharma industry make meaningful progress in the highly complex area of neuroscience.
December 8, 2025
·
5 min read
·
Bruce Leuchter
Press Releases
ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue
January 12, 2026
·
5 min read
Press Releases
ClearPoint Neuro Announces Agreement to Acquire IRRAS
November 6, 2025
·
9 min read
Press Releases
ClearPoint Neuro Announces Development and Demonstration of the Company’s Proprietary Robotic Neuro-Navigation System
October 2, 2025
·
7 min read
Press Releases
ClearPoint Neuro Reports Third Quarter 2025 Results
November 6, 2025
·
21 min read
1 of 76,176
Next
